Biostatistics Director – Oncology Strategy Lead (Relocation)

Green Key Resources; Gaithersburg (MD); On-site; USD 180,000 - 240,000; Full time

Benefits offered by this job

Relocation package

Job summary

Green Key Resources is seeking a Statistical Science Director for Late Oncology/Hematology to lead statistical strategy across product development and clinical programs. The role is based in or commutable to Gaithersburg, MD, with a full relo package and relocation assistance provided.

The candidate will shape study designs, drive analyses, and oversee regulatory submissions, while partnering with CROs and internal statisticians to deliver high-impact insights for oncology and hematology

Qualifications

• MSc or PhD in Statistics, Mathematics, or a closely related discipline.
• 7+ years of statistical experience in clinical trials, with at least 5 years in Oncology or Hematology.

Responsibilities

• Lead statistical design and strategy across clinical development programs.
• Provide statistical leadership for study designs, analyses, interpretation, and regulatory submissions.
• Quantify and communicate benefit, risk, value, and uncertainty around emerging product profiles.
• Represent Statistics in senior internal governance and decision-making forums.
• Partner with CROs and oversee work performed by internal and external statistical resources.
• Represent the organization externally with health authorities, advisory boards, conferences, workshops, and/or payer interactions.

Skills

Statistical leadership

Study design

Regulatory submissions

Leadership

CRO management

Education

MSc/PhD in Statistics

Mathematics

Job description

Green Key Resources is seeking a Statistical Science Director for Late Oncology/Hematology to lead statistical strategy across product development and clinical programs. The role is based in or commutable to Gaithersburg, MD, with a full relo package and relocation assistance provided.

The candidate will shape study designs, drive analyses, and oversee regulatory submissions, while partnering with CROs and internal statisticians to deliver high-impact insights for oncology and hematology